Non-clinical and Pre-clinical Testing to Demonstrate Safety of the Barostim Neo Electrode for Activation of Carotid Baroreceptors in Chronic Human Implants

Non-clinical and Pre-clinical Testing to Demonstrate Safety of the Barostim Neo Electrode for Activation of Carotid Baroreceptors in Chronic Human Implants

The Barostim neo™ electrode was developed by CVRx, Inc.to deliver baroreflex activation therapy (BAT)™ to treat hypertension and heart failure. The neo electrode concept was designed to deliver electrical stimulation to the baroreceptors within the carotid sinus bulb, while minimizing invasiveness o...

Full description

Bibliographic Details
Main Authors: Seth J. Wilks, Seth A. Hara, Erika K. Ross, Evan N. Nicolai, Paul A. Pignato, Adam W. Cates, Kip A. Ludwig
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-08-01
Series:Frontiers in Neuroscience
Subjects:
baroreflex activation therapy
electrode characterization
neuromodulation
bioelectronic medicine
electroceutical
preclinical
Online Access:http://journal.frontiersin.org/article/10.3389/fnins.2017.00438/full

Internet

http://journal.frontiersin.org/article/10.3389/fnins.2017.00438/full

Similar Items